Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113660372 | 11366037 | 2 | F | 20160802 | 20150811 | 20160810 | PER | US-BAYER-2015-391659 | BAYER | 0.00 | F | Y | 59.64000 | KG | 20160810 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113660372 | 11366037 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 21085 | FILM-COATED TABLET | ||||||||||
| 113660372 | 11366037 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 21085 | FILM-COATED TABLET | ||||||||||
| 113660372 | 11366037 | 3 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 21085 | 500 | MG | FILM-COATED TABLET | QD | ||||||
| 113660372 | 11366037 | 4 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 21085 | 500 | MG | FILM-COATED TABLET | QD | ||||||
| 113660372 | 11366037 | 5 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | TABLET | QD | ||||||
| 113660372 | 11366037 | 6 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | TABLET | QD | ||||||
| 113660372 | 11366037 | 7 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | TABLET | QD | ||||||
| 113660372 | 11366037 | 8 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | TABLET | QD | ||||||
| 113660372 | 11366037 | 9 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, QD | 0 | 500 | MG | MODIFIED-RELEASE FILM-COATED TABLET | QD | ||||||
| 113660372 | 11366037 | 10 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113660372 | 11366037 | 1 | Infection |
| 113660372 | 11366037 | 2 | Infection |
| 113660372 | 11366037 | 3 | Infection |
| 113660372 | 11366037 | 4 | Infection |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113660372 | 11366037 | Carpal tunnel syndrome | |
| 113660372 | 11366037 | Cataract | |
| 113660372 | 11366037 | Discomfort | |
| 113660372 | 11366037 | Emotional distress | |
| 113660372 | 11366037 | Fatigue | |
| 113660372 | 11366037 | Hypoaesthesia | |
| 113660372 | 11366037 | Injury | |
| 113660372 | 11366037 | Neuropathy peripheral | |
| 113660372 | 11366037 | Pain | |
| 113660372 | 11366037 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113660372 | 11366037 | 1 | 20070627 | 0 | ||
| 113660372 | 11366037 | 2 | 20080229 | 0 | ||
| 113660372 | 11366037 | 3 | 200706 | 0 | ||
| 113660372 | 11366037 | 4 | 200802 | 0 | ||
| 113660372 | 11366037 | 5 | 200901 | 0 | ||
| 113660372 | 11366037 | 6 | 200907 | 0 | ||
| 113660372 | 11366037 | 7 | 201101 | 0 | ||
| 113660372 | 11366037 | 8 | 201104 | 0 | ||
| 113660372 | 11366037 | 9 | 200910 | 0 | ||
| 113660372 | 11366037 | 10 | 2013 | 0 |